In BM samples with a detectable CLEC12A+ fraction of the CD34+CD38− cells, there was no significant difference in median fluorescence intensity of CLEC12A between CD34‐positive AML and MDS (P = 0·12). The gene discussed is CLEC12A; the disease is myelodysplastic syndrome.